Chemotherapy for advanced biliary tract carcinoma: A meta-analysis of randomized controlled trials

BACKGROUND: Although gemcitabine and platinum-based agents (GP) are currently regarded as the standard chemotherapy for advanced biliary tract cancer (BTC), the prognosis remains poor. Combinations with fluoropyrimidines and targeted therapy have demonstrated modest benefits. Therefore, we conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lawrence, Chen, Chiehfeng, Yen, Yun, Tam, Ka-Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370815/
https://www.ncbi.nlm.nih.gov/pubmed/27537589
http://dx.doi.org/10.1097/MD.0000000000004584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370815/
https://www.ncbi.nlm.nih.gov/pubmed/27537589
http://dx.doi.org/10.1097/MD.0000000000004584

Ejemplares similares